Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hwang Gyun Jeon

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
Cancer Research and Treatment|April 15, 2021
Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell CarcinomaGyu Sang Yoo, Won Park, Hongryull Pyo, et al.
Translational Oncology|November 22, 2017
Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary TractJi Yun Lee, Kyung Kim, Hyun Hwan Sung, et al.
Oncotarget|July 21, 2016
Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletionNakho Chang, Hye Won Lee, Joung Eun Lim, et al.
Journal of Cancer Research and Clinical Oncology|August 21, 2017
Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research CommitteeWan Song, Dong Hyeon Lee, Hwang Gyun Jeon, et al.
International Journal of Molecular Sciences|February 25, 2023
Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsJi Hyun Lee, Soohyun Hwang, ByulA Jee, et al.
The Journal of Urology|June 26, 2018
Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted TherapyMinyong Kang, Jae Young Park, Chang Wook Jeong, et al.
Korean Journal of Urology|December 19, 2015
Multiple cores of high grade prostatic intraepithelial neoplasia and any core of atypia on first biopsy are significant predictor for cancer detection at a repeat biopsyTae Sun Kim, Kwang Jin Ko, Seung Jea Shin, et al.
Korean Journal of Urology|April 25, 2013
The Establishment of K-CaP (the Multicenter Korean Prostate Cancer Database)Dong Hoon Lee, Seung Hwan Lee, Koon Ho Rha, et al.
Cancers|May 28, 2022
Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell CarcinomaByulA Jee, Eunjeong Seo, Kyunghee Park, et al.
Frontiers in Oncology|May 16, 2022
A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell CarcinomaHyunji Jo, Joohyun Hong, Hongsik Kim, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Cancer Research and Treatment|April 15, 2021
Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell CarcinomaGyu Sang Yoo, Won Park, Hongryull Pyo, et al.
Translational Oncology|November 22, 2017
Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary TractJi Yun Lee, Kyung Kim, Hyun Hwan Sung, et al.
Oncotarget|July 21, 2016
Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletionNakho Chang, Hye Won Lee, Joung Eun Lim, et al.
Journal of Cancer Research and Clinical Oncology|August 21, 2017
Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research CommitteeWan Song, Dong Hyeon Lee, Hwang Gyun Jeon, et al.
International Journal of Molecular Sciences|February 25, 2023
Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsJi Hyun Lee, Soohyun Hwang, ByulA Jee, et al.
The Journal of Urology|June 26, 2018
Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted TherapyMinyong Kang, Jae Young Park, Chang Wook Jeong, et al.
Korean Journal of Urology|December 19, 2015
Multiple cores of high grade prostatic intraepithelial neoplasia and any core of atypia on first biopsy are significant predictor for cancer detection at a repeat biopsyTae Sun Kim, Kwang Jin Ko, Seung Jea Shin, et al.
Korean Journal of Urology|April 25, 2013
The Establishment of K-CaP (the Multicenter Korean Prostate Cancer Database)Dong Hoon Lee, Seung Hwan Lee, Koon Ho Rha, et al.
Cancers|May 28, 2022
Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell CarcinomaByulA Jee, Eunjeong Seo, Kyunghee Park, et al.
Frontiers in Oncology|May 16, 2022
A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell CarcinomaHyunji Jo, Joohyun Hong, Hongsik Kim, et al.
Pageof 19